Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.02
UHS's Cash to Debt is ranked lower than
95% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. UHS: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
UHS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.27
Current: 0.02
0
0.27
Equity to Asset 0.45
UHS's Equity to Asset is ranked lower than
52% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 0.49 vs. UHS: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
UHS' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.49
Current: 0.45
0.26
0.49
Interest Coverage 70.06
UHS's Interest Coverage is ranked higher than
75% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 7.97 vs. UHS: 70.06 )
Ranked among companies with meaningful Interest Coverage only.
UHS' s Interest Coverage Range Over the Past 10 Years
Min: 4.46  Med: 8.5 Max: 78.52
Current: 70.06
4.46
78.52
F-Score: 7
Z-Score: 2.76
M-Score: -2.74
WACC vs ROIC
5.99%
11.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 13.65
UHS's Operating margin (%) is ranked higher than
71% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 6.99 vs. UHS: 13.65 )
Ranked among companies with meaningful Operating margin (%) only.
UHS' s Operating margin (%) Range Over the Past 10 Years
Min: 7.71  Med: 11.64 Max: 13.93
Current: 13.65
7.71
13.93
Net-margin (%) 7.43
UHS's Net-margin (%) is ranked higher than
62% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.82 vs. UHS: 7.43 )
Ranked among companies with meaningful Net-margin (%) only.
UHS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.64  Med: 6.04 Max: 7.53
Current: 7.43
3.64
7.53
ROE (%) 16.64
UHS's ROE (%) is ranked higher than
73% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 9.59 vs. UHS: 16.64 )
Ranked among companies with meaningful ROE (%) only.
UHS' s ROE (%) Range Over the Past 10 Years
Min: 11.67  Med: 16.42 Max: 19.9
Current: 16.64
11.67
19.9
ROA (%) 7.45
UHS's ROA (%) is ranked higher than
70% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. UHS: 7.45 )
Ranked among companies with meaningful ROA (%) only.
UHS' s ROA (%) Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 8.46
Current: 7.45
4.01
8.46
ROC (Joel Greenblatt) (%) 27.59
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 239 Companies
in the Global Medical Care industry.

( Industry Median: 19.38 vs. UHS: 27.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UHS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 15.92  Med: 23.33 Max: 27.01
Current: 27.59
15.92
27.01
Revenue Growth (3Y)(%) 8.00
UHS's Revenue Growth (3Y)(%) is ranked higher than
51% of the 175 Companies
in the Global Medical Care industry.

( Industry Median: 7.80 vs. UHS: 8.00 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UHS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 4.6  Med: 13.5 Max: 18.7
Current: 8
4.6
18.7
EBITDA Growth (3Y)(%) 6.60
UHS's EBITDA Growth (3Y)(%) is ranked lower than
55% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. UHS: 6.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UHS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -3.3  Med: 14.1 Max: 26.7
Current: 6.6
-3.3
26.7
EPS Growth (3Y)(%) 14.30
UHS's EPS Growth (3Y)(%) is ranked higher than
66% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. UHS: 14.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UHS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -11.3  Med: 14.3 Max: 31
Current: 14.3
-11.3
31
» UHS's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-28)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

UHS Guru Trades in Q3 2015

Ray Dalio 8,200 sh (New)
RS Investment Management 264,866 sh (+33.24%)
Private Capital 223,171 sh (+1.60%)
Ron Baron 409,748 sh (+0.03%)
Louis Moore Bacon Sold Out
Andreas Halvorsen Sold Out
Larry Robbins 964,895 sh (-0.71%)
Vanguard Health Care Fund 3,939,340 sh (-4.58%)
Westport Asset Management 685,391 sh (-5.41%)
Lee Ainslie 908,071 sh (-10.67%)
Chris Davis 82,120 sh (-28.52%)
Robert Olstein 20,600 sh (-49.76%)
Paul Tudor Jones 5,000 sh (-60.91%)
Joel Greenblatt 22,289 sh (-78.91%)
» More
Q4 2015

UHS Guru Trades in Q4 2015

Jim Simons 179,200 sh (New)
Jeremy Grantham 15,900 sh (New)
Steven Cohen 20,300 sh (New)
Joel Greenblatt 383,841 sh (+1622.11%)
Robert Olstein 32,000 sh (+55.34%)
Larry Robbins 1,209,602 sh (+25.36%)
Chris Davis 97,470 sh (+18.69%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Ray Dalio Sold Out
Paul Tudor Jones Sold Out
Private Capital 219,168 sh (-1.79%)
Westport Asset Management 621,391 sh (-9.34%)
Lee Ainslie 795,832 sh (-12.36%)
RS Investment Management 224,805 sh (-15.13%)
Ron Baron 270,003 sh (-34.11%)
» More
Q1 2016

UHS Guru Trades in Q1 2016

Paul Tudor Jones 3,517 sh (New)
John Paulson 54,000 sh (New)
Andreas Halvorsen 429,887 sh (New)
Jeremy Grantham 20,700 sh (+30.19%)
Lee Ainslie 966,544 sh (+21.45%)
Jim Simons 215,000 sh (+19.98%)
Robert Olstein 34,000 sh (+6.25%)
RS Investment Management 227,613 sh (+1.25%)
Chris Davis 97,650 sh (+0.18%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
Larry Robbins Sold Out
Steven Cohen 19,800 sh (-2.46%)
Westport Asset Management 571,391 sh (-8.05%)
Ron Baron 197,664 sh (-26.79%)
Private Capital 140,550 sh (-35.87%)
Joel Greenblatt 166,650 sh (-56.58%)
» More
Q2 2016

UHS Guru Trades in Q2 2016

Ray Dalio 1,500 sh (New)
Lee Ainslie 2,768,938 sh (+186.48%)
Joel Greenblatt 334,501 sh (+100.72%)
Paul Tudor Jones 3,571 sh (+1.54%)
Vanguard Health Care Fund 3,939,340 sh (unchged)
John Paulson Sold Out
Andreas Halvorsen Sold Out
Chris Davis Sold Out
Ron Baron 195,584 sh (-1.05%)
Private Capital 121,825 sh (-13.32%)
RS Investment Management 184,694 sh (-18.86%)
Robert Olstein 24,000 sh (-29.41%)
Westport Asset Management 400,827 sh (-29.85%)
Jeremy Grantham 13,000 sh (-37.20%)
Jim Simons 108,100 sh (-49.72%)
Steven Cohen 2,700 sh (-86.36%)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care
Compare:OTCPK:RMSYF, NYSE:DVA, OTCPK:SKHCY, OTCPK:MCFFY, NYSE:MD, NAS:WOOF, OTCPK:CAKFY, NAS:ACHC, NYSE:HLS, NAS:AMSG, OTCPK:NMHLY, OTCPK:LTGHY, NAS:LPNT, NYSE:THC, NYSE:CHE, NAS:SCAI, NYSE:AHS, NAS:AMED, NYSE:SEM, NYSE:CYH » details
Traded in other countries:UHS.Germany, UHID.USA,
Universal Health Services Inc, through its subsidiaries is engaged in the business of owning and operating acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers.

Universal Health Services Inc is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. It owned and/or operated 24 inpatient acute care hospitals, 3 free-standing emergency departments and 213 inpatient and 16 outpatient behavioral health care facilities located in 37 states, Washington, D.C., the United Kingdom, Puerto Rico and the U.S. Services provided by hospitals include general & specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. It provides capital resources as well as management services to facilities, including central purchasing, information services, finance & control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. Its reportable operating segments consist of acute care hospital services and behavioral health care services. The Other segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design & construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare & Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. Its hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. It faces competition for acquisition candidates mainly from other for-profit health care companies, as well

Ratios

vs
industry
vs
history
P/E(ttm) 16.97
UHS's P/E(ttm) is ranked higher than
77% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 25.80 vs. UHS: 16.97 )
Ranked among companies with meaningful P/E(ttm) only.
UHS' s P/E(ttm) Range Over the Past 10 Years
Min: 8.1  Med: 14.34 Max: 25.04
Current: 16.97
8.1
25.04
Forward P/E 16.26
UHS's Forward P/E is ranked higher than
67% of the 70 Companies
in the Global Medical Care industry.

( Industry Median: 18.87 vs. UHS: 16.26 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 16.97
UHS's PE(NRI) is ranked higher than
80% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 26.49 vs. UHS: 16.97 )
Ranked among companies with meaningful PE(NRI) only.
UHS' s PE(NRI) Range Over the Past 10 Years
Min: 8.26  Med: 15.28 Max: 27.86
Current: 16.97
8.26
27.86
Price/Owner Earnings (ttm) 11.77
UHS's Price/Owner Earnings (ttm) is ranked higher than
78% of the 86 Companies
in the Global Medical Care industry.

( Industry Median: 24.87 vs. UHS: 11.77 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
UHS' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 7.73  Med: 14.61 Max: 186.83
Current: 11.77
7.73
186.83
P/B 2.69
UHS's P/B is ranked lower than
53% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 2.56 vs. UHS: 2.69 )
Ranked among companies with meaningful P/B only.
UHS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 2.12 Max: 3.54
Current: 2.69
1.01
3.54
P/S 1.26
UHS's P/S is ranked higher than
58% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. UHS: 1.26 )
Ranked among companies with meaningful P/S only.
UHS' s P/S Range Over the Past 10 Years
Min: 0.33  Med: 0.76 Max: 1.68
Current: 1.26
0.33
1.68
PFCF 21.30
UHS's PFCF is ranked higher than
56% of the 111 Companies
in the Global Medical Care industry.

( Industry Median: 23.74 vs. UHS: 21.30 )
Ranked among companies with meaningful PFCF only.
UHS' s PFCF Range Over the Past 10 Years
Min: 8.37  Med: 15.41 Max: 325.73
Current: 21.3
8.37
325.73
POCF 9.21
UHS's POCF is ranked higher than
69% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 13.96 vs. UHS: 9.21 )
Ranked among companies with meaningful POCF only.
UHS' s POCF Range Over the Past 10 Years
Min: 3.21  Med: 8.23 Max: 23.76
Current: 9.21
3.21
23.76
EV-to-EBIT 12.81
UHS's EV-to-EBIT is ranked higher than
73% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 20.01 vs. UHS: 12.81 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.2  Med: 11.3 Max: 20
Current: 12.81
6.2
20
EV-to-EBITDA 9.54
UHS's EV-to-EBITDA is ranked higher than
75% of the 195 Companies
in the Global Medical Care industry.

( Industry Median: 14.08 vs. UHS: 9.54 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 7.8 Max: 12.3
Current: 9.54
4.3
12.3
PEG 1.44
UHS's PEG is ranked higher than
72% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. UHS: 1.44 )
Ranked among companies with meaningful PEG only.
UHS' s PEG Range Over the Past 10 Years
Min: 0.41  Med: 1.06 Max: 4.09
Current: 1.44
0.41
4.09
Shiller P/E 28.67
UHS's Shiller P/E is ranked lower than
51% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 27.77 vs. UHS: 28.67 )
Ranked among companies with meaningful Shiller P/E only.
UHS' s Shiller P/E Range Over the Past 10 Years
Min: 10.15  Med: 21.39 Max: 40.79
Current: 28.67
10.15
40.79
Current Ratio 1.27
UHS's Current Ratio is ranked lower than
54% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.39 vs. UHS: 1.27 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 0.97  Med: 1.56 Max: 1.98
Current: 1.27
0.97
1.98
Quick Ratio 1.17
UHS's Quick Ratio is ranked lower than
53% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.28 vs. UHS: 1.17 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 0.9  Med: 1.43 Max: 1.78
Current: 1.17
0.9
1.78
Days Inventory 41.61
UHS's Days Inventory is ranked lower than
72% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 18.31 vs. UHS: 41.61 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 8.44  Med: 10.33 Max: 44.68
Current: 41.61
8.44
44.68
Days Sales Outstanding 52.09
UHS's Days Sales Outstanding is ranked lower than
62% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 43.21 vs. UHS: 52.09 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 52.47 Max: 62.41
Current: 52.09
42.28
62.41

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.33
UHS's Dividend Yield is ranked lower than
95% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. UHS: 0.33 )
Ranked among companies with meaningful Dividend Yield only.
UHS' s Dividend Yield Range Over the Past 10 Years
Min: 0.17  Med: 0.47 Max: 0.99
Current: 0.33
0.17
0.99
Dividend Payout 0.06
UHS's Dividend Payout is ranked higher than
99% of the 137 Companies
in the Global Medical Care industry.

( Industry Median: 0.41 vs. UHS: 0.06 )
Ranked among companies with meaningful Dividend Payout only.
UHS' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.07 Max: 0.44
Current: 0.06
0.03
0.44
Dividend Growth (3y) 26.00
UHS's Dividend Growth (3y) is ranked higher than
77% of the 71 Companies
in the Global Medical Care industry.

( Industry Median: 14.50 vs. UHS: 26.00 )
Ranked among companies with meaningful Dividend Growth (3y) only.
UHS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 58.7
Current: 26
0
58.7
Forward Dividend Yield 0.33
UHS's Forward Dividend Yield is ranked lower than
95% of the 207 Companies
in the Global Medical Care industry.

( Industry Median: 1.79 vs. UHS: 0.33 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.64
UHS's Yield on cost (5-Year) is ranked lower than
88% of the 281 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. UHS: 0.64 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
UHS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.33  Med: 0.92 Max: 1.93
Current: 0.64
0.33
1.93
3-Year Average Share Buyback Ratio -0.20
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
75% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. UHS: -0.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.4  Med: 1.8 Max: 3.6
Current: -0.2
-1.4
3.6

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 16.17
UHS's Price/Tangible Book is ranked lower than
94% of the 167 Companies
in the Global Medical Care industry.

( Industry Median: 3.57 vs. UHS: 16.17 )
Ranked among companies with meaningful Price/Tangible Book only.
UHS' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.18  Med: 4.6 Max: 317.57
Current: 16.17
2.18
317.57
Price/Projected FCF 1.00
UHS's Price/Projected FCF is ranked higher than
78% of the 90 Companies
in the Global Medical Care industry.

( Industry Median: 1.69 vs. UHS: 1.00 )
Ranked among companies with meaningful Price/Projected FCF only.
UHS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.15 Max: 33.96
Current: 1
0.74
33.96
Price/DCF (Earnings Based) 0.65
UHS's Price/DCF (Earnings Based) is ranked higher than
93% of the 30 Companies
in the Global Medical Care industry.

( Industry Median: 1.68 vs. UHS: 0.65 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.67
UHS's Price/Median PS Value is ranked lower than
86% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. UHS: 1.67 )
Ranked among companies with meaningful Price/Median PS Value only.
UHS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.08 Max: 2.16
Current: 1.67
0.5
2.16
Price/Peter Lynch Fair Value 2.44
UHS's Price/Peter Lynch Fair Value is ranked higher than
51% of the 43 Companies
in the Global Medical Care industry.

( Industry Median: 2.48 vs. UHS: 2.44 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
UHS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.43  Med: 1.27 Max: 3.63
Current: 2.44
0.43
3.63
Price/Graham Number 3.49
UHS's Price/Graham Number is ranked lower than
66% of the 113 Companies
in the Global Medical Care industry.

( Industry Median: 2.54 vs. UHS: 3.49 )
Ranked among companies with meaningful Price/Graham Number only.
UHS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.97  Med: 1.92 Max: 12.53
Current: 3.49
0.97
12.53
Earnings Yield (Greenblatt) (%) 7.80
UHS's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. UHS: 7.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UHS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5  Med: 8.9 Max: 16.1
Current: 7.8
5
16.1
Forward Rate of Return (Yacktman) (%) 12.42
UHS's Forward Rate of Return (Yacktman) (%) is ranked higher than
60% of the 105 Companies
in the Global Medical Care industry.

( Industry Median: 10.19 vs. UHS: 12.42 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
UHS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 9.8  Med: 18.6 Max: 28
Current: 12.42
9.8
28

More Statistics

Revenue (TTM) (Mil) $9,424
EPS (TTM) $ 7.04
Beta0.81
Short Percentage of Float1.94%
52-Week Range $100.82 - 141.58
Shares Outstanding (Mil)97.38

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 10,184 10,857 12,070
EPS ($) 7.38 8.13 8.84
EPS w/o NRI ($) 7.38 8.13 8.84
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($) 0.40 0.40 0.40
» More Articles for NYSE:UHS

Headlines

Articles On GuruFocus.com
Healthcare Dividend Growth Stocks: Part 1 Aug 04 2016 
Westport Funds' Final Quarterly Commentary Jul 19 2016 
Quality Guru Stocks Include Amgen, Comcast Apr 21 2016 
Westport Trims Nearly 39% of Stakes in Portfolio Feb 12 2016 
Westport Select Cap Fund Third Quarter Commentary Oct 16 2015 
Westport Fund Third Quarter Commentary Oct 16 2015 
Olstein Funds 2015 Annual Letter to Shareholders Sep 24 2015 
Baron Funds Comments on Universal Health Services Inc. Aug 18 2015 
Westport Asset Management Sells Bulk of Two Stakes Aug 17 2015 
Mariko Gordon's Highest-Performing Stocks Jul 28 2015 

More From Other Websites
Universal Health Services, Inc. To Present At Two Upcoming Healthcare Conferences Aug 23 2016
Universal Health Buys Medical Center in Nevada, Stock Down Aug 17 2016
Universal Health Services, Inc. Expands Acute Care Operations In Nevada Aug 16 2016
Universal Health Services, Inc. Expands Acute Care Operations In Nevada Aug 16 2016
Hospital stocks take a hit as Aetna retreats from Obamaca... Aug 16 2016
4 Stocks, 4 trades: STX, UHS, PANW & GOOGL Aug 16 2016
UNIVERSAL HEALTH SERVICES INC Financials Aug 12 2016
UNIVERSAL HEALTH SERVICES INC Files SEC form 10-Q, Quarterly Report Aug 05 2016
Universal Health Services, Inc. :UHS-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016 Aug 05 2016
EA, Ruger, Fitbit, Qorvo, Cerner, Paycom Top Earnings Views Aug 02 2016
Acadia's Acquisition Spree Has Been A Poor Use of Capital Jul 29 2016
Universal Health Realty reports 2Q results Jul 27 2016
Universal Health Realty reports 2Q results Jul 27 2016
Universal Health (UHS) Q2 Earnings In-Line, Revenues Beat Jul 27 2016
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 27 2016
[$$] Universal Health Revenue Rises But Misses Expectations Jul 26 2016
Universal Health Services posts 2Q profit Jul 26 2016
Universal Health Services posts 2Q profit Jul 26 2016
Universal Health Services, Inc. Reports 2016 Second Quarter Financial Results Jul 26 2016
Universal Health Services, Inc. Reports 2016 Second Quarter Financial Results Jul 26 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)